10-year remissions with CAR T therapy in B-cell lymphoma
June 24, 2026
June 24, 2026
PHILADELPHIA, Pennsylvania, June 24 -- The University of Pennsylvania Perelman School of Medicine posted the following news:
* * *
10-year remissions with CAR T therapy in B-cell lymphoma
*
After a median follow-up of 10 years, more than one-third of patients with large B-cell lymphoma and nearly half of patients with follicular lymphoma who received a single infusion of tisagenlecleucel-the CAR T cell therapy developed by Carl June, MD, that w . . .
* * *
10-year remissions with CAR T therapy in B-cell lymphoma
*
After a median follow-up of 10 years, more than one-third of patients with large B-cell lymphoma and nearly half of patients with follicular lymphoma who received a single infusion of tisagenlecleucel-the CAR T cell therapy developed by Carl June, MD, that w . . .